pentobarbital will lessen the extent or influence of mifepristone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. CYP3A4 inducers have not been studied, coadministration not encouraged by maker
pentobarbital and olopatadine intranasal the two enhance sedation. Stay clear of or Use Alternate Drug. Coadministration will increase danger of CNS depression, which may result in additive impairment of psychomotor overall performance and trigger daytime impairment.
pentobarbital will reduce the level or impact of propafenone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Unfamiliar.
pentobarbital will minimize the extent or impact of buprenorphine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
fentanyl transdermal and pentobarbital each boost sedation. Stay away from or Use Alternate Drug. Limit use to patients for whom alternate treatment options are inadequate
pentobarbital will decrease the extent or result of phenytoin by affecting hepatic enzyme CYP2C9/ten metabolism. Use Caution/Keep track of.
pentobarbital will reduce the extent or effect of abemaciclib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. Coadministration of abemaciclib with sturdy CYP3A4 inducers decreases plasma concentration of abemaciclib and its metabolites.
Contraindicated (one)pentobarbital will lower the extent or influence of cobimetinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Avoid coadministration. Potent or reasonable CYP3A inducers might decrease cobimetinib systemic publicity by >eighty% and lessen its efficacy.
Contraindicated. CYP3A4 is liable for the development and elimination of cariprazine's Energetic metabolites. The effect of CYP3A4 inducers on cariprazine publicity has not been evaluated along with the net outcome is unclear.
pentobarbital will reduce the extent or effect of mestranol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
fentanyl intranasal and pentobarbital equally increase sedation. Stay away from or Use Alternate Drug. Restrict use to clients for whom choice procedure choices are inadequate
Keep track of Intently (one)pentobarbital will reduce the extent or impact of exemestane by influencing 戊巴比妥鈉製作 hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. For patients receiving exemestane which has a powerful CYP3A4 inducer the proposed dose of exemestane is fifty mg everyday following a food.
pentobarbital will lessen the level or impact of finasteride by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Mysterious.
pentobarbital will decrease the extent or effect of estrogens esterified by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.